Synapse - Vincent Miller

Search Within

Vincent Miller

Results (270)

Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer

Journal Article

Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials

Journal Article

Jackman, D. M.; Miller, V. A.; Cioffredi, L. A.; Yeap, B. Y.; Jänne, P. A.; Riely, G. J.; Ruiz, M. G.; Giaccone, G.; Sequist, L. V.; Johnson, B. E.
Clinical Cancer Research (2009)

Fulltext@MSK | Save

Gemcitabine nephrotoxicity and hemolytic uremic syndrome: Report of 29 cases from a single institution

Journal Article

Glezerman, I.; Kris, M. G.; Miller, V.; Seshan, S.; Flombaum, C. D.
Clinical Nephrology (2009)

Fulltext@MSK | Save

Comparison of CISH and FISH for detection of EGFR copy number in lung adenocarcinoma and correlation with EGFR and KRAS mutation status and EGFR immunoreactivity

Meeting Abstract

Varella-Garcia, M.; Ladanyi, M.; Kris, M. G.; Li, A.; Chitale, D. A.; Rekhtman, N.; Riely, G. J.; Miller, V. A.; Hirsch, F. R.; Zakowski, M. F.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib

Meeting Abstract

Jackman, D. M.; Sequist, L. V.; Cioffredi, L.; Gallegos Ruiz, M.; Janne, P. A.; Giaccone, G.; Miller, V. A.; Johnson, B. E.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Acquired resistance to epidermal growth factor receptor (EGFR) kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma

Meeting Abstract

Bean, J.; Riely, G. J.; Balak, M.; Marks, J. L.; Ladanyi, M.; Miller, V. A.; Pao, W.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Activity and tolerance of XL647 in NSCLC patients with acquired resistance to EGFR-TKIs: Preliminary results of a phase II trial

Meeting Abstract

Miller, V. A.; Wakelee, H. A.; Lara, P. N.; Cho, J.; Chowhan, N. M.; Costa, D.; Vrindavanam, N.; Yanagihara, R.; Pennell, N.; Lynch, T. J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Reproducibility of computed tomography (CT) measurements of lung cancer

Meeting Abstract

James, L. P.; Zhao, B.; Moskowitz, C. S.; Riely, G. J.; Miller, V. A.; Guo, P.; Ginsberg, M. S.; Kris, M. G.; Schwartz, L. H.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

Meeting Abstract

Riely, G. J.; Kris, M. G.; Marks, J. L.; Li, A.; Chitale, D. A.; Riedel, E. R.; Hsu, M.; Pao, W.; Miller, V. A.; Ladanyi, M.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Use of BIBW 2992, a novel irreversible EGFR/HER2 TKI, to induce regression in patients with adenocarcinoma of the lung and activating EGFR mutations: Preliminary results of a single-arm phase II clinical trial

Meeting Abstract

Yang, C.; Shih, J.; Chao, T.; Tsai, C.; Yu, C.; Yang, P.; Streit, M.; Shahidi, M.; Miller, V. A.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save